Equity (Details) - Warrant [Member] - $ / shares |
12 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Beginning balance | 426,788 | 921,438 |
Warrants issued | 289,294 | 400,002 |
Warrants Expired | 0 | (772,628) |
Warrants Exercised | (46,615) | (122,024) |
Ending balance | 669,467 | 426,788 |
Warrants exercied | $ 2.52 | $ 2.80 |
Maximum [Member] | ||
Beginning balance | 2.52 | 3.08 |
Warrants issued | 7.00 | |
Warrants expired | 0 | 3.08 |
Ending balance | 7.00 | 2.52 |
Minimum [Member] | ||
Beginning balance | 2.52 | 2.52 |
Warrants issued | 5.60 | 2.52 |
Warrants expired | 0 | 2.52 |
Ending balance | $ 2.52 | $ 2.52 |
X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|